Literature DB >> 33521715

Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection.

Matt Lechner1,2, Nicholas Counsell3, Jacklyn Liu2, Nicholas Eynon-Lewis1, Santdeep Paun1, Valerie J Lund4, Sam Jayaraj1, Carl Philpott5,6.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33521715      PMCID: PMC7832605          DOI: 10.1016/S2666-5247(20)30096-3

Source DB:  PubMed          Journal:  Lancet Microbe        ISSN: 2666-5247


× No keyword cloud information.
On May 18 2020, Public Health England added new loss of taste or smell to the recognised symptoms associated with COVID-19, consistent with those listed by the Centers of Disease Control and Prevention (Atlanta, GA, USA) and WHO.1, 2 The identification of loss of sense of smell as a symptom of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is particularly important for frontline health-care workers who are at high risk of both contracting and spreading SARS-CoV-2. Anonymous self-reported questionnaires were distributed to staff at Barts Health NHS Trust (London, UK). In total, 262 health-care workers from four hospitals completed the questionnaire between April 17 and 23, 2020, of whom, 59% were women, 58% were younger than 40 years, and 6% were older than 60 years, providing a representative sample of the patient-facing workforce. 73 (28%) of 262 participants had been tested for SARS-CoV-2; 56 of whom had a confirmed positive test by PCR. 168 (64%) of 262 responders reported losing their sense of smell or taste in the previous 2 months, with 94 (48%) reporting mild symptoms, 93 (48%) reporting moderate symptoms, and seven (4%) reporting severe symptoms. Losing sense of smell or taste and developing COVID-19 were strongly associated. Participants who lost their sense of smell or taste were more likely to have a positive SARS-CoV-2 test than those who did not report these symptoms (odds ratio 4·9, 95% CI 1·4–17·1, p=0·01). 97 participants responded to a follow-up survey done between May 22 and 27, 2020; 45 (46%) reported that they had completely regained their sense of smell or taste, 41 (42%) had recovered partially, and seven (7%) had not recovered (not applicable for four [4%] responders). 71 (73%) of 97 responders had continued to work as normal. Around two-thirds of participants reported loss of sense of smell or taste in the previous 2 months, which is highly indicative of SARS-CoV-2 infection (appendix p 2). In comparison, the prevalence of self-reported smell loss varies between 1·4% and 15·3% across published studies.4, 5 To date, testing for health-care workers in the National Health Service has been scarce and only recently has been made more widely available. Thus, a large proportion of health-care workers might have already been infected with SARS-CoV-2 and had only mild symptoms, resulting in only a small number of health-care workers being tested. In conclusion, awareness and early recognition of anosmia and hyposmia is needed to identify, urgently test, and isolate affected health-care workers to prevent further spread of disease.
  3 in total

1.  Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management.

Authors:  M Lechner; D Chandrasekharan; K Jumani; J Liu; S Gane; V J Lund; C Philpott; S Jayaraj
Journal:  Rhinology       Date:  2020-08-01       Impact factor: 3.681

Review 2.  Position paper on olfactory dysfunction.

Authors:  T Hummel; K L Whitcroft; P Andrews; A Altundag; C Cinghi; R M Costanzo; M Damm; J Frasnelli; H Gudziol; N Gupta; A Haehne; E Holbrook; S C Hong; D Hornung; K B Hüttenbrink; R Kamel; M Kobayashi; I Konstantinidis; B N Landis; D A Leopold; A Macchi; T Miwa; R Moesges; J Mullol; C A Mueller; G Ottaviano; G C Passali; C Philpott; J M Pinto; V J Ramakrishnan; P Rombaux; Y Roth; R A Schlosser; B Shu; G Soler; P Stjärne; B A Stuck; J Vodicka; A Welge-Luessen
Journal:  Rhinol Suppl       Date:  2017-03

3.  The Epidemiology of Olfactory Disorders.

Authors:  Jingpu Yang; Jayant M Pinto
Journal:  Curr Otorhinolaryngol Rep       Date:  2016-04-07
  3 in total
  3 in total

Review 1.  CRISPR-Cas systems for diagnosing infectious diseases.

Authors:  Anastasiya Kostyusheva; Sergey Brezgin; Yurii Babin; Irina Vasilyeva; Dieter Glebe; Dmitry Kostyushev; Vladimir Chulanov
Journal:  Methods       Date:  2021-04-09       Impact factor: 4.647

2.  Results of a hospitalization policy of asymptomatic and pre-symptomatic COVID-19-positive long-term care facility residents in the province of Salzburg-a report from the AGMT COVID-19 Registry.

Authors:  Florian Huemer; Gabriel Rinnerthaler; Benedikt Jörg; Patrick Morre; Birgit Stegbuchner; Elisabeth Proksch; Stefanie Fleimisch; Hannes Oberkofler; Iris Kremser; Richard Greil; Alexander Egle
Journal:  Geroscience       Date:  2021-04-10       Impact factor: 7.713

Review 3.  Post-viral effects of COVID-19 in the olfactory system and their implications.

Authors:  Michael S Xydakis; Mark W Albers; Eric H Holbrook; Dina M Lyon; Robert Y Shih; Johannes A Frasnelli; Axel Pagenstecher; Alexandra Kupke; Lynn W Enquist; Stanley Perlman
Journal:  Lancet Neurol       Date:  2021-07-30       Impact factor: 44.182

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.